These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35342878)

  • 1. Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication.
    Lai X; Yu Y; Xian W; Ye F; Ju X; Luo Y; Dong H; Zhou YH; Tan W; Zhuang H; Li T; Liu X; Ding Q; Xiang K
    iScience; 2022 Apr; 25(4):104136. PubMed ID: 35342878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The
    Hu Y; Meng X; Zhang F; Xiang Y; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for characterizing the inhibition of SARS-CoV-2 infection by a protein of interest in cultured cells.
    Lai X; Zhuang H; Li T; Xiang K
    STAR Protoc; 2022 Dec; 3(4):101802. PubMed ID: 36345374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants.
    Tietjen I; Cassel J; Register ET; Zhou XY; Messick TE; Keeney F; Lu LD; Beattie KD; Rali T; Tebas P; Ertl HCJ; Salvino JM; Davis RA; Montaner LJ
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0077221. PubMed ID: 34543092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
    Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro.
    Hetrick B; Yu D; Olanrewaju AA; Chilin LD; He S; Dabbagh D; Alluhaibi G; Ma YC; Hofmann LA; Hakami RM; Wu Y
    Cell Biosci; 2021 May; 11(1):100. PubMed ID: 34051873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cell culture system modeling the SARS-CoV-2 life cycle.
    Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q
    PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
    Hu J; Gao Q; He C; Huang A; Tang N; Wang K
    Genes Dis; 2020 Dec; 7(4):551-557. PubMed ID: 32837985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2.
    Ngwe Tun MM; Sakura T; Sakurai Y; Kurosaki Y; Inaoka DK; Shioda N; Yasuda J; Kita K; Morita K
    Trop Med Health; 2022 Jan; 50(1):6. PubMed ID: 34991723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
    Xu C; Wang A; Marin M; Honnen W; Ramasamy S; Porter E; Subbian S; Pinter A; Melikyan GB; Lu W; Chang TL
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Lactoferrin, a Natural Mammalian Milk Protein, Assist in the Battle against COVID-19?
    Einerhand AWC; van Loo-Bouwman CA; Weiss GA; Wang C; Ba G; Fan Q; He B; Smit G
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
    Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
    Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.